Semler Scientific has filed with the SEC a $500 million offering to fund Bitcoin purchases.
Medical technology company Semler Scientific has filed for a $500 million mixed shelf offering with the U.S. Securities and Exchange Commission (SEC), announcing that it plans to use the proceeds to potentially purchase more Bitcoin.
In a preliminary prospectus filed with the SEC, Semler stated that it “may, from time to time, offer and sell securities in one or more offerings with an aggregate value of up to $500,000,000.”
The offering may involve various types of securities, and Semler intends to provide specific terms and conditions in future prospectus supplements. The company also noted that the securities may be sold directly to investors or through agents, underwriters or brokers.
Semler shares, which trade on the Nasdaq Capital Markets under the ticker SMLR, have experienced significant volatility over the past year. Between Jan. 1, 2024 and April 14, 2025, the shares rose to as high as $74.73 and fell to as low as $21.03, with the most recent closing price being $34.26.
The company attributed this price fluctuation to lower Q1 2024 earnings, the adoption of a Bitcoin-focused treasury policy, and market volatility surrounding crypto assets. However, it noted that the stock fluctuations were not due to any material changes in financial condition or operations.
Semler Scientific first entered the bitcoin space last year, joining a growing list of public companies allocating institutional funds to the digital asset.
